Recent Post

hero image

Focus FS Launches $8m AI Project

  • Feb 02, 2026
hero image

Seline Wins $8500 at UNB’s Apex Event

  • Feb 01, 2026
hero image

HCi3 Invests $1M in Oberland Agriscience

  • Jan 29, 2026

recent news

Innovacorp’s Oceans Adopter Program

  • Oct 11, 2016
  • Peter Moreira

Six Nova Scotia ocean technology companies have been selected to participate in Innovacorp’s Early Adopter Program, the provincial innovation agency said.

Each of the companies in the program will receive as much as $20,000 to help finance the

read more

Athletigen Releases Flagship Product

  • Oct 11, 2016
  • Peter Moreira

Athletigen Technologies, a Halifax company dedicated to genetics for athletes, on Monday released its flagship product Iris.

Iris produces human performance insights developed from partnerships with world-class athletes and performance experts. The

read more

Wise: Best Time Ever for Startups

  • Oct 10, 2016
  • Peter Moreira

A familiar face on the East Coast startup circuit, Sean Wise had a limited time to answer a range of questions at Invest Atlantic and summed them up in a simple sentence: it’s a great time to be an entrepreneur.

Wise is a professor of

read more

Job of the Week: Resson Growing

  • Oct 10, 2016
  • Peter Moreira

Our Jobs of the Week column this week features an opportunity for a developer interested in working for one of the hottest tech companies in the region.

The Fredericton agriculture technology company Resson, which this year announced it had raised

read more

Cape Breton Startups on Display

  • Oct 07, 2016
  • Peter Moreira

Cape Breton startups had to compete with Donald Trump, Jeff Hutcheson and Jim Balsillie at the Cape Breton Partnership’s Investor Summit on Thursday, but the young companies more than held their own.

The summit is the annual conference of the

read more

Sullivan Balances Appili’s Risks

  • Oct 06, 2016
  • Carol Moreira

Pathogens’ growing antibiotic resistance is a global concern. Halifax drug discovery firm Appili Therapeutics Inc. is developing its own solutions, and scouring the world for potential drugs with which to grow the company.

CEO Kevin Sullivan said

read more

Squiggle Park Joins Fierce Founders

  • Oct 06, 2016
  • Peter Moreira

As it launches the pilot of its first product, Halifax-based Squiggle Park has been accepted into the Fierce Founders Accelerator, a new program in Kitchener-Waterloo for female tech entrepreneurs.

The Halifax educational technology company,

read more

Clearpath Raises US$30M in VC

  • Oct 06, 2016
  • Peter Moreira

Kitchener-based Clearpath Robotics Inc. said  Wednesday it has raised US$30 million (C$39.5 million) in a follow-on round led by iNovia Capital of Montreal.

The funding is on top of a $14 million round it closed early in 2015.

The other investors

read more

Startups Help To Retain Young People

  • Oct 04, 2016
  • Peter Moreira

About four years ago, a trio of game developers came together to form a Bedford-based gaming studio called Alpha Dog Games, and quietly began to grow.

The team started with three founders – two of whom, Jeff Cameron and Shawn Woods, are still with

read more

Eyesover Exceeds 2016 Sales Target

  • Oct 04, 2016
  • Peter Moreira

As a former cabinet minister in New Brunswick, Craig Leonard knows how quickly and decisively public opinion develops on social media. It helps him as the CEO of Eyesover, a new Fredericton-based social media monitoring company.

Eyesover is the

read more

Propel Growth Seeks Candidates

  • Oct 03, 2016
  • Peter Moreira

Propel ICT is looking for a few good startups – with the potential of becoming a few great companies.

The regional Atlantic Canadian accelerator is hoping to identify successful startups that would be candidates for the Propel Growth program. This

read more

FDA Grants Soricimed Orphan Status

  • Oct 03, 2016
  • Peter Moreira

Soricimed Biopharma Inc., the Moncton-based biotech company developing peptide-based cancer treatments, has announced the U.S. Food and Drug Administration has granted orphan drug designation to its flagship compound for the treatment of pancreatic

read more